US › Healthcare

GlucoTrack Inc (GCTK)

US · Healthcare · Medical Devices

$0.60+44.28%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-4.3M

Profit YoY

+36.6%

EPS

$-4.64

EPS estimate

$0.00

Key statistics

Market cap

$3.7M

P/E

0.1

Forward P/E

0.0

P/B

0.65

Book value

$-0.34

EPS (TTM)

$6.27

52-week high

$14.14

52-week low

$0.25

50-day MA

$0.45

200-day MA

$2.45

Beta

0.66

Shareholding

Insiders

15.78%

Institutions

3.72%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.72%
Ikarian Capital, LLC	0.70%
HRT FINANCIAL LLC	0.62%
GRANITE ISLANDS PRIVATE WEALTH, LLC	0.24%
BOOTHBAY FUND MANAGEMENT, LLC	0.21%
Vanguard Fiduciary Trust Co	0.07%
ALERUS FINANCIAL NA	0.06%
Tower Research Capital LLC	0.05%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for GlucoTrack Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.